These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22437628)

  • 1. Zoledronic acid improves bone mineral density in pediatric spinal cord injury.
    Ooi HL; Briody J; McQuade M; Munns CF
    J Bone Miner Res; 2012 Jul; 27(7):1536-40. PubMed ID: 22437628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.
    Simm PJ; Johannesen J; Briody J; McQuade M; Hsu B; Bridge C; Little DG; Cowell CT; Munns CF
    Bone; 2011 Nov; 49(5):939-43. PubMed ID: 21820091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children.
    Ward KA; Roberts SA; Adams JE; Mughal MZ
    Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury.
    Shapiro J; Smith B; Beck T; Ballard P; Dapthary M; BrintzenhofeSzoc K; Caminis J
    Calcif Tissue Int; 2007 May; 80(5):316-22. PubMed ID: 17417700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in bone mineral density at cortical and trabecular sites in the tibia and femur during the first year of spinal cord injury.
    Coupaud S; McLean AN; Purcell M; Fraser MH; Allan DB
    Bone; 2015 May; 74():69-75. PubMed ID: 25596521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
    Israeli RS; Rosenberg SJ; Saltzstein DR; Gottesman JE; Goldstein HR; Hull GW; Tran DN; Warsi GM; Lacerna LV
    Clin Genitourin Cancer; 2007 Mar; 5(4):271-7. PubMed ID: 17553207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure.
    Streeten EA; Ramirez S; Eliades M; Jaimungal S; Chandrasekaran S; Kathleen R; Holmes Morton D; Puffenberger EG; Herskovitz R; Leonard MB
    Bone; 2015 Aug; 77():17-23. PubMed ID: 25892485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid administration failed to prevent bone loss at the knee in persons with acute spinal cord injury: an observational cohort study.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Martinez L; Kirshblum SC; Spungen AM
    J Bone Miner Metab; 2015 Jul; 33(4):410-21. PubMed ID: 25158630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone steady-state is established at reduced bone strength after spinal cord injury: a longitudinal study using peripheral quantitative computed tomography (pQCT).
    Frotzler A; Berger M; Knecht H; Eser P
    Bone; 2008 Sep; 43(3):549-55. PubMed ID: 18567554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions.
    Szalay EA
    J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
    Recker RR; Delmas PD; Halse J; Reid IR; Boonen S; García-Hernandez PA; Supronik J; Lewiecki EM; Ochoa L; Miller P; Hu H; Mesenbrink P; Hartl F; Gasser J; Eriksen EF
    J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury.
    Edwards WB; Schnitzer TJ; Troy KL
    Osteoporos Int; 2014 Mar; 25(3):1005-15. PubMed ID: 24190426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trabecular bone microarchitecture is deteriorated in men with spinal cord injury.
    Modlesky CM; Majumdar S; Narasimhan A; Dudley GA
    J Bone Miner Res; 2004 Jan; 19(1):48-55. PubMed ID: 14753736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss.
    Duan Y; Turner CH; Kim BT; Seeman E
    J Bone Miner Res; 2001 Dec; 16(12):2267-75. PubMed ID: 11760841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
    Szulc P; Munoz F; Duboeuf F; Marchand F; Delmas PD
    Bone; 2006 Apr; 38(4):595-602. PubMed ID: 16249130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of reduced peak accrual of bone and age-related bone loss to osteoporosis at the spine and hip: insights from the daughters of women with vertebral or hip fractures.
    Tabensky A; Duan Y; Edmonds J; Seeman E
    J Bone Miner Res; 2001 Jun; 16(6):1101-7. PubMed ID: 11393787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
    Brufsky AM; Harker WG; Beck JT; Bosserman L; Vogel C; Seidler C; Jin L; Warsi G; Argonza-Aviles E; Hohneker J; Ericson SG; Perez EA
    Cancer; 2012 Mar; 118(5):1192-201. PubMed ID: 21987386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis.
    Little DG; Smith NC; Williams PR; Briody JN; Bilston LE; Smith EJ; Gardiner EM; Cowell CT
    J Bone Miner Res; 2003 Jul; 18(7):1300-7. PubMed ID: 12854841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.